Viewing Study NCT06157892


Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2025-12-26 @ 9:14 AM
Study NCT ID: NCT06157892
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2023-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module